Malignant Tumors of the Larynx - 22/08/11
Key Points |
• | Squamous cell carcinoma (SCC) accounts for 85% to 95% of malignant laryngeal tumors. |
• | Tobacco and alcohol are the two most important risk factors for the development of laryngeal SCC. |
• | In the United States, laryngeal SCC occurs in the glottis more frequently than in the supraglottis. Subglottic SCC is rare. |
• | Laryngeal preservation may be achieved in properly selected cases by the use of conservation laryngeal surgery (partial laryngectomy), radiotherapy, or chemoradiotherapy. |
• | Early laryngeal SCC (stage I, II) is generally treated with single-modality therapy: either surgery or radiotherapy. |
• | Advanced laryngeal SCC (stage III, IV) is generally treated with combined-modality therapy. |
• | Endoscopic partial laryngectomy (transoral laser microsurgery) has similar oncologic outcomes to open partial laryngectomy with less functional morbidity. |
• | Total laryngectomy is the gold standard surgical procedure for the treatment of advanced laryngeal SCC. |
• | Concurrent chemoradiotherapy in a properly executed organ preservation protocol is the most effective nonsurgical treatment for advanced laryngeal SCC. |
• | The stage of disease is the most important factor predictive of prognosis, with N (nodal) stage more significant than T (tumor) stage. |
Plan
© 2010 Mosby, Inc. Tous droits réservés.© 2010 Ann Otol Rhinol Laryngol. Publié par Elsevier Masson SAS. Tous droits réservés.© 2010 Ann Otol Rhinol Laryngol. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L'accès au texte intégral de ce chapitre nécessite l'achat du livre ou l'achat du chapitre.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à ce produit ?